chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial reported received on 03 October 2008 from a healthcare professional. A 36 year old male patient, with no concurrent illnesses, no known allergies, and was not taking any other medication, had received on 29 September 2008, a "Hep B" vaccine (Trade name, manufacturer name, lot number, route and site of administration not provided); and the following day, on 30 September 2008 in the A.M., the patient received a first intradermal left forearm tuberculin test with TUBERSOL (lot # C2908AA). Per the reporter, 15 minutes after receiving the TUBERSOL test, the patient developed left arm pain described as being from the finger tips to the underarm, this was accompanied by throat tightness (without shortness of breath) and a headache that lasted five hours. The patient did not report these adverse events to a physician, and subsequently came into the physicians office to get the tuberculin test read on 03 October 2008. At that time, the tuberculin test was negative. Per the reporter, the needle size used for the tuberculin test was a TB needle 5/8 inch. No relevant diagnostic tests or laboratory data were performed. At the time of this report, the patient had recovered; however the date of recovery was not provided. Follow-up information was received from a healthcare professional on 31 October 2008. It was clarified that the hepatitis B vaccine (manufacturer Glaxosmithkline, lot number AHBVB640AA, expiration date 12 March 2011) was administered to the patient's upper right arm on 23 September 2008 (not 29 September 2008 as previously reported) It was also clarified that the patient's symptoms started one hour (not 15 minutes as previously reported) after receiving the TUBERSOL test. The patient did not contact the doctor's office at the time of  the "reaction" and he was not seen by a physician. No allergy tests were performed. It was reported that no follow-up was required as the health department was not aware of the events until the tuberculin test was read on 03 October 2008. The patient stated that recovery was after 0.5 hours. The reporter indicated there was no additional information at this time.
Initial misuse report received on 07 October 2013 from a health care professional. A patient, whose medical history and concomitant medications were not reported, received a intradermal dose of FLUZONE ID (lot number and expiry date was not reported). It was reported that the patient whose age falls outside the products indication was given this vaccine. No reaction was reported. List of documents held by sender: none.
no additional adverse experience; Improperly stored vaccine administered; This spontaneous report as received from a nurse refers to a 4-year-old male patient. Pertinent medical history, drug reactions, allergies and concomitant medications were not reported.  On 16-AUG-2021, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) (lot number: U009261, expiration date: 19-SEP-2022; dose and route of administration not provided). The vaccine was stored in temperature 38 degrees Fahrenheit for 67 hours 30 minutes and 0 seconds. There was no previous temperature excursion.  No adverse event was reported.
Information has been received from a consumer concerning her daughter, a 20 year old female, with history of epilepsy who was vaccinated with the first dose of GARDASIL last week (in OCTOBER 2008). Concomitant therapy included LAMICTAL and TRILEPTAL, as well as VNS implant. While taking anti-seizure medications the patient had not had seizures in "quite a while", except for last week. The patient experienced half a dozen seizures within 2 hours after getting her first dose of GARDASIL. She contacted doctor for medical attention. At the time of report, the patient did not recover from this event. This is one of several reports of siblings. Upon internal review, "half a dozen seizures" was considered to be a other important medical event. Additional information ahs been requested.
This spontaneous report was received from a physician refers to a patient of unknown age and gender. On 13-APR-2015, the patient was vaccinated with improperly stored (Oka-Merck) PROQUAD lot # K02766, expiry date 08-JUN-2015. This is one of the several reports received from the same reporter. Additional information has been requested.
"Heart racing", flush-Repeated no s/s of first injection. C/O feeling dizziness  PR:85       SPO2:99% Room Air                  B/P: 170/90
This spontaneous report was received from a pharmacist and refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical history provided.  On an unknown date, the patients were vaccinated with an improperly stored doses of GARDASIL 9 lot # M007728 with an expiration date 21-MAR-2018 for prophylaxis (dose, route of administration were not reported). No adverse symptoms were reported. Administered doses of GARDASIL 9 experienced the temperature excursion from 47 degrees Fahrenheit to 77 degrees Fahrenheit for 3 hours. There was no previous temperature excursion. Digital data logger was involved. This is one of two reports received from the same reporter. Additional information has been requested.; Sender's Comments:  US-009507513-1706USA005006:
Patient received her first COVID vaccination on 4/14. The day after her vaccination, she had fever and body aches which have since resolved. Also had a HA which has since improved. However, since COVID vaccination she has still felt "foggy" and fatigued. States that she sometimes feels that she can't get a good breath and is feeling anxious. Admits that she feels shaky and tired. Admits that she is currently on her menses which started the day after the COVID vaccination and has been heavier than normal which might attribute to her fatigue. Admits lack of appetite but denies nausea, vomiting, diarrhea, fever, chills, HA, SOB, dizziness, tremors, CP, HAs, weakness, numbness, tingling.
I received 2 Moderna Vaccine doses in 6/21 and had severe side effects form the second dose. Including severe headache, nauseas, chills, body aches. It is a requirement for a new job I get the booster and I was given that dose on 1/31/22, within several hours I began having very severe side effect symptoms as the previous second dose however, it is more severe this time. I began to have severe headache, body aches, chills, dizziness, sleepiness, physical exhaustion and nausea. I am still not feeling very well and slowly am trying to heal. I have not seen a Dr as of yet.
I totally forgot, I never had the second shot; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 63-year-old patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (received 1st dose at the beginning of Covid).   On an unknown date, the patient did not receive the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 16-SEP-2022 Reporter's Comment: The patient stated shortly after that his/her elderly mother moved in etc. and patient totally forgot that and never had second shot. The patient asked what to do now.  The patient reported that it's been three years and asked did he/she start from scratch. The patient asked to pharmacist and got two different answers. Additional Supportive Information: Till the time of reporting, the patient did not receive 2nd dose of Shingles vaccine, which led to incomplete course of vaccination. The follow-up would not possible, as no contact details were available.
pain in both arms; little swelling; fever; chills; joint pain; This case was reported by a consumer via other manufacturer and described the occurrence of pain in arm in a 52-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included MEASLES MUMPS RUBELLA VACCINE for prophylaxis.   Concurrent medical conditions included diabetes, hypertension, hypothyroidism, chronic migraine, blood cholesterol increased and drug allergy (pencillin, Levaquin and latex). Concomitant products included sitagliptin (Januvia), losartan, hydrochlorothiazide, atorvastatin calcium (Lipitor) and levothyroxine.   On 19th February 2021, the patient received the 1st dose of Shingrix and the 1st dose of MEASLES MUMPS RUBELLA VACCINE (subcutaneous). On an unknown date, less than a month after receiving Shingrix and an unknown time after receiving MEASLES MUMPS RUBELLA VACCINE, the patient experienced pain in arm, swelling, fever, chills and joint pain. On an unknown date, the outcome of the pain in arm, swelling, fever, chills and joint pain were recovered/resolved.   It was unknown if the reporter considered the pain in arm, swelling, fever, chills and joint pain to be related to Shingrix.  Additional details was reported as follows: Patient received Shingrix and experienced pain in arm, swelling, fever, chills and joint pain. It was unknown if the reporter considered the pain in arm, swelling, fever, chills and joint pain to be related to MEASLES MUMPS RUBELLA VACCINE. No other information was available.
Saturday - injection site pain, tiredness, severe headache and lower back ache, muscle pain, chills, joint pain, fever of 100.5, nausea, felling unwell (in bed all day), swollen lymph nodes under right arm, no appetite, dizziness - took Tylenol  Sunday - injection site pain, tiredness, lower back ache, swollen lymph nodes under right arm not appetite
No adverse symptoms were reported; The patient was inadvertently administered an expired dose of GARDASIL 9; The vaccine has experienced a temperature excursion during transport from the pharmacy to the doctor's office; This spontaneous report was received from a pharmacist regarding a 21 year-old female patient. The patient's concurrent conditions, pertinent medical history, drug reactions, allergies, and concomitant therapies were not provided.   On 19-NOV-2019, the patient was inadvertently administered an expired dose (expired product administered) HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) for prophylaxis, lot number R024264, expiration date 29-OCT-2019 (dose and route of administration was not provided). Also, the medical assistant who administered the vaccine called back to confirmed that the vaccine had experienced a temperature excursion (product storage error) during transport from the pharmacy to the doctor's office. The vaccine experienced temperature excursion of 73 degrees Fahrenheit (°F) for 30 minutes. No data logger was involved. There was no more temperature excursions reported. No adverse symptoms were reported (no adverse events).
My first symptoms were scratchy throat and the next day nasal congestion and the third day I started having a dry cough. That caused me to do a self-test which came back positive. I repeated that test on the fourth day which was positive and caused me to make an appointment with the local clinic. I got an appointment the clinic confirmed the positive test, and I was unable to take PAXLOVID because of the medication I was on. I was given an antiviral medication and over the counter medication. I took the prescribed medication for five days and then retested and I was negative. The symptoms were mild, and I had no high fever.
pt became extremely irritable 8hr following vax, refused to feed, & became dehydrated by the next day prompting ER visit the next evening & oral rehydration therapy;sx resolved, feeding improved by 48hr;
Noticed three rashes on my right arm where my first shot was given, circular redness.  Maybe a week before  I actually went to the doctor. The doctor said appeared to be ringworm.  Many more appeared on my arms, legs, right foot, butt cheek. Doctor gave me ointment. Gave pills because got worse. I did not take because concern of liver damage and loss of taste.
Information was rec'd from a RN. Pt post vaccine developed a strange lupus like rash on her face that was mask like and her eyelids were swollen.
SHORTNESS OF BREATHE, TROUBLE BREATHING, OXYGEN DROPPED TO 85%  SWEATING, TACHYCARDIA RATE 111 FEVER
red blotches on skin of both arms, hands (with palms) and neck; Scratchy throat; Itchy sensation on her shoulders and back; Hives; Injection site pain; headache; This is a spontaneous report received from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EP6955) via an unspecified route of administration in the arm left on 20Mar2021 at 10:00 (at the age of 58-years) as a single dose for COVID-19 immunisation. Medical history included GERD (gastroesophageal reflux disease), IBS (irritable bowel syndrome), high cholesterol, obesity and allergy to acyclovir. Concomitant medications included Pantoprazole (MANUFACTURER UNKNOWN) 40 mg daily, Multivitamins (MANUFACTURER UNKNOWN), THERA TEARS within two weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Mar2021 patient experienced injection site pain, headache within 30 minutes of vaccination. On 20Mar2021, at 18:00 the patient experienced red blotches on skin of both arms, hands (with palms) and neck, hives, scratchy throat and itchy sensation on her shoulders and back. Six hours after vaccine, the patient had red blotches on skin on both arms, hands (with palms) and neck, with a few hives that were itchy, and a scratchy throat. It subsided in about two hours. On second day, she had some itchy sensation on her shoulders and back with no blotches or hives. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events hives and scratchy throat was resolved on an unknown date in Mar2021 and injection site pain, headache, red blotches on skin of both arms, hands (with palms) and neck, and itchy sensation on her shoulders and back was resolving at the time of the report.   No follow-up attempts are needed. No further information is expected.
**Pt c/o 'chest pressure' 15 minutes after covid vaccine. Also c/o  lightheadedness. Denies nausea.  Pt placed in room and employee from Surgery came  over to attach vital signs monitor. Dr. from ER happened to be in this  area and checked on pt. Dr. from Surgery Dept. also here. 1700 Pt states  he is much better, denies SOB, any chest pressure or pain and denies dizziness or  lightheadedness. Pt dischrged at 1705 per ambulation to home.  1644: BP 155/73       P 75       SPO2 96 RA 1654: BP        P 72       SPO2 97       T 98.5 1700: BP 146/77       P 67       SPO2 96
Pt called to report raised, red, itchy skin at the injection site one week after COVID vaccination. She states it is the size of a silver dollar. Informed patient that this is know to occur. VAERS report completed as this is not listed on the usual side effects. Advised pt that it should resolve in 1-7 days and she should still receive the second COVID vaccine.
Evening of February 24th it felt like left wrist was sprained but no trauma had occurred. Non-dominant hand.  Pain persisted on/off for 2 months, brace worn, ice and ibuprofen used,  xray taken in April. Ultrasound therapy done several times in May/June. Orthopedist seen June 22, determined to be tendonitis in the left wrist.  Cortisone injected July 8. Pain flared September 28, topical pain reliever prescribed. Minor flare after 3rd Covid Vaccine dose October 1, 2021 with low level pain persisting.
Patient reports somnolence in the first 24 hours.  Injection site pain for about 1 week after injection.  Also had pain in his right forearm from day 3-14 after vaccine.  Lastly - reported that his right tricep muscle was twitching.  This also started on day 3 after the vaccine.  Still occurring intermittently on day 15 post vaccine.
Extreme restless legs (couldn't stop moving legs); Vertigo; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 08May2021 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included hysterectomy due to ovarian cyst and signs of ovarian cancer, kidney stones and vertigo. The patient did not have any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included bupropion XL (MANUFACTURER UNKNOWN) and topiramate (MANUFACTURER UNKNOWN); both for an unknown indication, on an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 17Apr2021 at 11:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination.  On 09May2021 at 00:00, 1 day after the vaccination, the patient experienced extreme restless legs (couldn't stop moving legs) and vertigo which began 24 hours after vaccination. The events had not resulted in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of events extreme restless legs (couldn't stop moving legs) was resolved on 10May2021 at 00:00 after the duration of 24 hours, while vertigo was resolved on 11May2021 at 00:00, after the duration of 48 hours.  No follow-up attempts are needed. No further information is expected.
Patient stated that she felt cold/flu like symptoms and hasn't slept well. Her arm is also bright red and swollen in about a 6 inch diameter from where she received the shot.
Developed a severe stiff neck the next day and it has continued. Can not attribute the stiff neck to any other reason. The entire neck is sore to the base of my head.
Has tremors but that they got worst; Feeling faint; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Has tremors but that they got worst) and DIZZINESS (Feeling faint) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 056M23A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Johnson and Johnson (Patient took first dose of Johnson and Johnson vaccine.). Past adverse reactions to the above products included No adverse event with Johnson and Johnson. Concomitant products included ALPRAZOLAM (XANAX) for an unknown indication.    On 10-Apr-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced TREMOR (Has tremors but that they got worst) and DIZZINESS (Feeling faint). At the time of the report, TREMOR (Has tremors but that they got worst) had not resolved and DIZZINESS (Feeling faint) outcome was unknown.            No treatment details were reported.   This case was linked to MOD-2022-538041 (Patient Link).
12/27/21  presenting today for Fever (sore throat, chills, headache) Review of Systems  Constitutional: Positive for activity change, chills, fatigue and fever. Negative for appetite change and diaphoresis.  HENT: Positive for congestion and sore throat.   Respiratory: Positive for cough. Negative for shortness of breath and wheezing.   Gastrointestinal: Negative for abdominal pain, diarrhea, nausea and vomiting.  Genitourinary: Negative for dysuria.  Musculoskeletal: Positive for myalgias. Negative for arthralgias.  Skin: Negative for rash.  Neurological: Negative for headaches.
Shivering/chills all night long with headache, headache and fatigue on 12/17. Below injection site I have a large (about 2" by 2") red welt, hard to the touch.
Started feeling fatigued on 5/15 and congestion. Tested positive on 5/16. No fever but scratchy throat. Contact NP on 5/17 and started Paxlovid. Symptoms have rapidly improved since then.
Cold symptoms runny nose sore throat congestion, all 2 days post 1st dose, I called health line and I went to get a covid test and the test was negative. I also had a dime size rash on my right 4th toe. I took nyquil and dayquil
High fever, vomiting, eyes swollen shut 1 - 1 1/2 hours after shot administration.
Second dose of Moderna was administered with 3 weeks interval rather than 4 weeks. Parent was counseled by DO and continued communication given by DO.
Patient received Pfizer COVID vaccine on 8/17/21 (only 1 dose). Patient had  ~3 weeks history of shortness of breath, cough, generalized weakness, fatigue, loss of appetite, and intermittent diarrhea before he was admitted to our facility on 8/23/21 for acute respiratory with hypoxia due to COVID-19 pneumonia. Patient was discharged home on 8/27 in stable condition on 2L nasal cannula with a prescription of dexamethasone to complete a 10 day course. Patient did not receive remdesivir due to being out of window.
Patient reported via telephone getting Shingrix subcutaneously in the back of her left arm instead of intramuscularly. She reported side effects of feeling tired and achy, no appetite, muscle cramps, and feeling like she was coming down with the flu today (less than 24 hours after vaccine was received). She also said she had a raised, painful, red area larger than a silver dollar at the injection site.  Patient called around one hour after after noticing the red area on her arm and was relaxing in a chair after having taken Motrin to help with the pain. She does not wish to receive the second dose after having the reaction and doing further research that the error that happened to her is a common one.
Pt had redness and swelling at site of injection.  Pt. developed rash and pain across right side of face and scalp. Dr. diagnosed shingles and gave pt acylovir.  Pt. still had rash but less pain when she showed me a week later.
Systemic: Chest Tightness / Heaviness / Pain-Mild, Systemic: nervousness-Medium, Systemic: Hypertension-Severe, Additional Details: Patient felt chest pain and nervous after receiving moderna COVID vaccine in left arm. 2pm: BP 200/11 HR 68, 2:05pm BP 186/106 HR 67; 2:37pm BP 208/118 HR 71. Patient mentioned he did not take his BP medications today. Cound not establish what patient's baseline BP is. Ambulance was called to make sure patient was not having hypertensive emergency. EMS took patient to the hospital.
At approximately 2100, father noticed that he felt warm, gave him a dose of ibuprofen.  The child subsequently had emesis times one around 2200.  This was nonbloody and nonbilious.  Approximately 20 minutes prior to arrival, the patient was asleep on the couch when he had an episode where his entire body went rigid, his eyes rolled back in his head, and the father was concerned that the patient did not have a pulse.  At that time, the father started CPR, however, the episode remitted spontaneously.  The patient seemed slightly confused and maybe a little bit sleepy and has gradually returned towards his baseline.  Subsequently he was transported by Ambulance for further evaluation.  Per ER note:  This likely represents a simple febrile seizure as the patient has returned to his normal baseline within a reasonable period of time.  There is no further testing or intervention needed at this point in time.